Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01113736 · ClinicalTrials.gov registry record · Phase 1
Pilot Study Evaluating the Efficacy of AlloMEM After Loop Ileostomy
A Phase 1 study, sponsored by University Hospitals Cleveland Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT01113736 is a Phase 1 study that has completed, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 10 participants.
The verdict
NCT01113736, a Phase 1 study, has completed, sponsored by University Hospitals Cleveland Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
The objective of this study is to investigate whether the use of Human Peritoneal Membrane (HPM) in a temporary loop ileostomy is beneficial to patients. Benefit will be defined, for purposes of this study, as a decrease in adhesions resulting in decreased operative time during ileostomy closure, with promotion of peritoneal remodeling.
Interventions
- BIOLOGICAL AlloMEM™
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2010-01 |
| Est. Completion | 2012-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01113736
The ClinicalTrials.gov registry entry for NCT01113736 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University Hospitals Cleveland Medical Center, which has 230 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AlloMEM™ is the first listed.
NCT01113736 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01113736 about?
NCT01113736 is a clinical study titled "Pilot Study Evaluating the Efficacy of AlloMEM After Loop Ileostomy". The objective of this study is to investigate whether the use of Human Peritoneal Membrane (HPM) in a temporary loop ileostomy is beneficial to patients. Benefit will be defined, for purposes of this study, as a decrease in adhesions resulting in decreased operative time during ileostomy closure, wi...
What is the current status of trial NCT01113736?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2010-01. Estimated completion is 2012-07.
What interventions are being tested in trial NCT01113736?
The interventions under investigation include: AlloMEM™ (BIOLOGICAL).
Who is sponsoring clinical trial NCT01113736?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.